Suppr超能文献

新型三苯基膦功能化取代嘧啶的合成及体外抗菌和抗生物膜活性评价。

Synthesis and in vitro evaluation of antibacterial and antibiofilm activities of novel triphenylphosphonium-functionalized substituted pyrimidines.

机构信息

Department of Chemistry of Natural Compounds, V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, NAS of Ukraine, Kyiv, Ukraine.

Laboratory of Pharmacology of Antimicrobials, SI Institute of Pharmacology and Toxicology, NAMS of Ukraine, Kyiv, Ukraine.

出版信息

Chem Biol Drug Des. 2024 Feb;103(2):e14483. doi: 10.1111/cbdd.14483.

Abstract

The increase in the prevalence of antibiotic-resistant pathogens leads to a decrease in the number of antimicrobial agents for the treatment of infections and prompts researchers to search for new effective antimicrobial drugs. This study reports the synthesis of novel triphenylphosphonium-functionalized substituted pyrimidines and in vitro evaluation of their antibacterial and antibiofilm activity. Most of the synthesized derivatives showed high antibacterial activity (MIC = 0.39-1.56 μg/mL) against the methicillin-resistant strain of S. aureus 222. Compounds 2a and 11 exhibited a high level of antibiofilm activity against S. aureus 222 and E. coli 311. The triphenylphosphonium-containing pyrimidines 11 and 2a reduced S. aureus 222 biofilm formation by 99.1% and 95.8%, respectively. In addition, compound 2a was the most active against E. coli 311 biofilm formation (the biomass decreased by 98.4%).

摘要

抗生素耐药病原体的流行率增加导致可用于治疗感染的抗菌药物数量减少,促使研究人员寻找新的有效抗菌药物。本研究报告了新型三苯基膦功能化取代嘧啶的合成及其体外抗菌和抗生物膜活性评价。大多数合成衍生物对耐甲氧西林金黄色葡萄球菌 222 具有很高的抗菌活性(MIC=0.39-1.56μg/mL)。化合物 2a 和 11 对金黄色葡萄球菌 222 和大肠杆菌 311 表现出很高的抗生物膜活性。含三苯基膦的嘧啶 11 和 2a 分别使金黄色葡萄球菌 222 生物膜形成减少了 99.1%和 95.8%。此外,化合物 2a 对大肠杆菌 311 生物膜形成的活性最高(生物量减少了 98.4%)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验